News

27.03.2019

EU collaboration in health for better access: Taking stock and looking to the future

The Patient Access Partnership (PACT) gathered a wide range of stakeholders at the MEP Interest Group on Access to Healthcare…

From laboratory to your medicine: EMA’s new booklet explains it all

27.03.2019

Have you ever wondered how a new medicine is approved for the treatment of your disease?  We have the answer….

Oceans of Hope: sailing with MS in 2019

08.03.2019

We have previously featured the Oceans of Hope (OoH) yacht that circumnavigated the world in 2014. There were approximately 100…

08.03.2019

More than 21,000 people call for action on ocrelizumab for Primary Progressive MS in the UK

More than 21,000 people have signed a petition launched by the MS Society UK, calling for ocrelizumab to be made…

After 20 years, the “Is MS Treatment Still a Lottery?” campaign has achieved its objective in Croatia

08.03.2019

The Croatian MS Society presented new guidelines for Multiple Sclerosis (MS) treatment which, after 20 years, will finally provide timely…

Danish MS Society offers Trauma Releasing Exercises (TRE) training for MS patients

08.03.2019

TRE (tension and trauma releasing exercises) is a therapeutic method for relieving trauma and stress. The method was developed by…

08.03.2019

21st State of Art Symposium around the challenges of MS treatment in Switzerland

Paediatric MS and MS in old age were the two main topics neurologists explored at the 21st State of the…

Increased number of monthly physiotherapy sessions for people with MS in Greece

08.03.2019

Thanks to the continuous effort of the Hellenic Federation of Persons with MS, the Greek National Health Care Provider (EOPYY)…

Event report: “Lifting the Burden of Neurological Disorders in Europe” panel discussion in the European Parliament

08.03.2019

The European Federation of Neurological Associations (EFNA) and the European Academy of Neurology (EAN) jointly organized an event entitled “Lifting…

1 21 22 23 24 25 69